Ciprofloxacin And Dexamethasone Suspension
Product Images NDC 0832-1430

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 0832-1430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ciprofloxacin 01)

Chemical structure diagram of Ciprofloxacin Hydrochloride, showing its molecular framework including a fluorine atom, piperazine ring, and carboxyl group, along with HCl and H2O notations indicating hydrochloride and hydrate forms.*

FDA Label Image

Figure 2 (Ciprofloxacin 02)

Chemical structure of Dexamethasone, shown as a detailed molecular diagram with labeled carbon, hydrogen, oxygen, and fluorine atoms.*

FDA Label Image

Figure A (Ciprofloxacin 03)

An instructional illustration showing hands being washed under running water from a faucet, demonstrating proper handwashing technique.*

FDA Label Image

Figure B (Ciprofloxacin 04)

An instructional illustration showing a person holding a small bottle, likely a suspension for otic use, with one hand while using the other hand to apply pressure to the bottle's tip. This image suggests the proper technique for preparing or administering ear drops.*

FDA Label Image

Figure C (Ciprofloxacin 05)

An instructional line drawing depicting a person lying on their side with the ear exposed for administration of an otic suspension. The illustration is likely intended to show the proper head position for applying Ciprofloxacin and Dexamethasone otic suspension.*

FDA Label Image

Figure D (Ciprofloxacin 06)

An instructional illustration showing a hand administering ear drops into the ear canal of a person, demonstrating the proper technique for using an otic suspension medication such as Ciprofloxacin and Dexamethasone.*

FDA Label Image

Figure E (Ciprofloxacin 07)

An instructional illustration demonstrating ear drop administration for Ciprofloxacin and Dexamethasone otic suspension. Four frames show a hand pressing the tragus of the ear to help deliver medication, with arrows indicating downward and upward movements. The final frame shows pressing the tragus five times.*

FDA Label Image

Figure F (Ciprofloxacin 08)

An instructional diagram showing how to position the ear for administration of an otic suspension. The first image shows a hand manipulating the ear, the second directs pulling the ear upward labeled 'UP', and the third illustrates pulling the ear backward labeled 'BACK' to facilitate ear drop instillation.*

FDA Label Image

Carton (Ciprofloxacin 09)

Packaging label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP by Upsher-Smith Laboratories, LLC. The label indicates a 7.5 mL suspension for auricular use only, with directions to shake well before use. It includes storage instructions, ingredients, and sterility information. The label is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.